Regenicin Names Former U.S. Marine Corp Operations Officer, Christopher Hadsall, Chief Operating Officer
Tuesday October 5th, 2010
Commenting on the announcement,
Mr. Hadsall most recently held several key managerial positions with Able Body Labor, a staffing solutions company serving their customers from over 170 branches in 25 states and putting more than 125,000 people to work each year. From 2006 to 2010, Mr. Hadsall was the Regional Manager of Able Body's Westward Ho II subsidiary expansion program where he was responsible for the regional P&L as well as the creation and implementation of a multi-million dollar expansion plan. Under his leadership the region's revenue generation for the company increased five-fold. Prior to heading up that regional expansion, Mr. Hadsall served as Director of Development and Veterans Affairs where he developed and managed targeted government sales programs focusing on transitioning service members and veterans. During his tenure at Able Body, Mr. Hadsall founded the
Prior to working with Able Body, Mr. Hadsall served our country for eight years as a decorated Operations and Intelligence Officer for the
Commenting on his decision to join Regenicin™, Mr. Hadsall stated "Having served in the military and working with wounded veterans over the course of the last 12 years, I am keenly aware of the tremendous benefits of Regenicin's PermaDerm products for treating wounded soldiers as well as other victims of serious burns or injuries requiring grafting. I am looking forward to applying my operational management skills along with my expertise in working with hospitals and care organizations to help Regenicin™ realize its huge growth potential."
About Regenicin™, Inc.
Regenicin™, Inc. is a clinical-stage company developing next-generation tissue-engineered skin substitutes to restore the qualities of healthy human skin. Regenicin™ is a publicly traded company, with headquarters in
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the
SOURCE